Delek Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$9.57M Sell
105,953
-107,100
-50% -$10.2M 0.37% 86
2019
Q1
$20M Sell
213,053
-80,000
-27% -$7M 0.83% 43
2018
Q4
$19.3M Buy
293,053
+89,937
+44% +$6.64M 0.88% 33
2018
Q3
$18.1M Sell
203,116
-34,300
-14% -$3.03M 0.76% 37
2018
Q2
$18.9M Buy
237,416
+53,276
+29% +$4.42M 0.81% 31
2018
Q1
$16.4M Buy
184,140
+49,525
+37% +$4.75M 0.84% 32
2017
Q4
$14.2M Buy
+134,615
New +$15.2M 0.76% 39

Other funds holding CELG

Delek Group's CELG Position: Q2 2019 in Review

Delek Group reduced its Celgene Corp (CELG) stake by 50% in Q2 2019, selling an estimated $10.2M and leaving 105,953 shares worth $9.57M. The position accounts for 0.37% of the portfolio, ranked #86.

Delek Group first reported a position in CELG in Q4 2017 and has held it in 7 quarters since. The position peaked at $20M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Delek Group held 105,953 shares of Celgene Corp worth $9.57M as of Q2 2019.
  • Delek Group sold 107,100 Celgene Corp shares in Q2 2019, an estimated $10.2M.
  • Celgene Corp made up 0.37% of Delek Group's portfolio in Q2 2019, its #86 holding.
  • Delek Group first reported a position in Celgene Corp in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Celgene Corp position peaked at $20M in Q1 2019.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.